Medical Device Industry News

MassDevice.com +3 | The top 3 medtech stories for September 19, 2014

September 19, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

TriVascular Tech's stent graft recall could hurt the bottom line

September 19, 2014 by Arezu Sarvestani

TriVascular Technologies updates on its Ovation Prime aortic stent graft recall, warning that the company may take a hit as it loses some product from its inventory.

TriVascular Tech's stent graft recall could hurt the bottom line

California medtech maker TriVascular Technologies (NSDQ:TRIV) issued an update today on the recall of certain of its Ovation Prime aortic stent grafts, advising that the measure may drag down full-year revenues.

FTC approves Cerner's $1.3B Siemens health IT buy

September 19, 2014 by Arezu Sarvestani

Cerner gets federal approval for its $1.3 billion acquisition of Siemens' health information technology business.

FTC approves Cerner's $1.3B Siemens health IT buy

House passes bill to repeal, refund medical device tax

September 19, 2014 by Brad Perriello

The U.S. House of Representatives passes a jobs package that would repeal the medical device tax and issue refunds for all levies paid since the 2.3% excise tax went into effect last year.

House passes bill to repeal, refund medical device tax

UPDATED Sept. 19, 2014, with comment from MDMA, MITA and AdvaMed. 

The U.S. House of Representatives voted yesterday to repeal and refund the medical device tax and promptly went into recess until after the mid-term elections in November.

Medtronic settles CRM kickbacks case with final, $362k payment

September 19, 2014 by Brad Perriello

Medtronic makes the final payment in the $11.1 million settlement of allegations that it ran a kickbacks scheme to influence sales of its cardiac rhythm management products, but admits no wrongdoing.

Medtronic settles CRM kickbacks case with final, $362k payment

Medigus secures $5.6M in funding, reveals positive outcomes from study of its MUSE surgical endostapling device | Medtech funding for the week of September 15, 2014

September 19, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Medigus raises $5.6M, touts clinical results for acid reflux device; Funding: InSightec raises $12.5M from Chinese backers; Corindus raises $26.6M for vascular robot; Intrinsic Therapeutics raises $17.2M for spinal surgery devices

Medigus raises $5.6M, touts clinical results for acid reflux device

September 12, 2014 by Arezu Sarvestani

Medigus raises $5.6M, touts clinical results for acid reflux device

Did Boston Scientific lose $74M mesh trial over an email? | MassDevice.com On Call

September 19, 2014 by Arezu Sarvestani

The most recent Boston Scientific mesh lawsuit, which cost the company $74 million, featured an internal email that may have made a major impact on the jury.

MassDevice.com On Call

MASSDEVICE ON CALL — Medtech titan Boston Scientific's (NYSE:BSX) logged a major loss after winning a few rounds in the ongoing lawsuits over its vaginal sling implants, and the deciding factor may have been the revelation of an internal company email.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp